AngioDynamics ANGO Med Device — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's med device — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's med device — net sales?
- AngioDynamics (ANGO) reported med device — net sales of $41.14M in Q4 2025.
- How has AngioDynamics's med device — net sales changed year-over-year?
- AngioDynamics's med device — net sales increased by 1.2% year-over-year, from $40.66M to $41.14M.
- What is the long-term trend for AngioDynamics's med device — net sales?
- Over 4 years (2021 to 2025), AngioDynamics's med device — net sales has grown at a -8.4% compound annual growth rate (CAGR), from $235.28M to $165.84M.
- What does med device — net sales mean?
- Net sales for the medical device segment reflect the total revenue generated from the sale of medical, surgical, and diagnostic devices after accounting for returns, allowances, and discounts. This metric is the primary indicator of market demand and the segment's top-line growth trajectory. It provides insight into the company's ability to capture market share within the competitive healthcare technology landscape.